Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brent A Tetri, MD
St. Louis University School of Medicine
Principal Investigator - Mohammad S Siddiqui, MD
Virginia Commonwealth University Medical Center
Principal Investigator - Naga Chalasani, MD
Indiana University
Principal Investigator - Ram Subramanian, MD
Emory University Hospital (Transplant Center Clinical Research)
Principal Investigator - Stephen Harrison, MD
Brooke Army Medical Center
Principal Investigator - Thomas Schiano, MD
The Mount Sinai Medical Center (Division of Liver Diseases)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Brooke Army Medical Ctr.
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2013
- Primary completion
- 28 Feb 2015
- Completion
- 28 Feb 2015
- Last update posted
- 23 Feb 2015
- Registered enrollment
- 31
- Registry id
- NCT01899859
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.